NEW YORK—Optigenex Inc. announced an expansion of licensing rights granted to Promethean Corp. for the manufacture, distribution and marketing of branded dietary supplements, and oral and topical cosmeceutical products containing AC-11®, a patented, all-natural rainforest botanical extract manufactured by Optigenex. Under the terms of the parties' new alliance, Promethean, through its wholly owned subsidiary, Ceres Living, will reach out to new markets with its acclaimed "AIO Premium Cellular Health™" line of advanced dietary supplements containing AC-11, and will increase focus on developing a global sales initiative for specially formulated next generation topical skin care products with AC-11.
AC-11 is a proprietary ingredient that helps the body's natural ability to repair damaged DNA as a result of overexposure to the sun and other environmental stressors. The new contract greatly enlarges the scope of Promethean's "territory" for marketing AC-11 products beyond the North American distribution channels that formed the major portion of the parties' initial relationship beginning in 2009. Promethean will now have the right to promote its AC-11 product lines worldwide, except in Japan and Turkey, and will enjoy expanded exclusivity in certain channels and countries.
Daniel Zwiren, president and CEO of Optigenex Inc., said: "From the start last year, our company's association with Promethean and Ceres Living has been special. Finding a way to expand our interactions into something more akin to a product development and marketing partnership than a supplier-customer relationship was something we at Optigenex realized early on should be a priority goal. I am pleased to see that we were able to achieve the goal so quickly, and to know the AC-11 brand and our message of DNA health will now receive the highest possible level of global exposure with Promethean."